Profile
Thomas A.
Kramer joined Hansen Medical, Inc. as Senior Director of Clinical Affairs in September 2006 and was appointed Vice President of Clinical Affairs in February 2007.
He was Director of Clinical Engineering for Broncus Technologies, Inc. from March 2004 to August 2006 and Director of Research and Development from March 2002 to February 2004.
From April 2000 to March 2002, Mr. Kramer was Director of Quality for Guidant Corporation and Director of Research and Development from September 1999 to April 2000.
He received a BS degree from Cal Poly State University and an MS from San Diego State University.
Former positions of Thomas A. Kramer
| Companies | Position | End |
|---|---|---|
Broncus Technologies, Inc.
 Broncus Technologies, Inc. Medical SpecialtiesHealth Technology Broncus Technologies is a medical technology company focused on developing and commercializing innovative solutions for lung diseases. With LungPoint™, physicians plan bronchoscopic procedures and navigate to locations in the lungs accurately and quickly. Its line of Yield™ catheters are used to obtain tissue samples and detect blood vessels. Its patented treatment method, Airway Bypass using Exhale® Drug-Eluting Stents, is being investigated to determine if it can provide the first minimally-invasive treatment option for homogeneous, or diffuse, emphysema, the form of the disease experienced by the majority of emphysema patients. | Chief Tech/Sci/R&D Officer | 2005-12-31 |
| HANSEN MEDICAL, INC. | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Hansen Medical, Inc.
 Hansen Medical, Inc. Medical SpecialtiesHealth Technology Hansen Medical, Inc. develops, manufactures, and sells medical robotics designed for positioning, manipulation, and stable control of catheters and catheter-based technologies. It offers Sensei Robotic Catheter System which allows physicians to instinctively navigate flexible catheters with stability and control in interventional procedures within the atria heart chambers. The company was founded by Frederic H. Moll, Daniel T. Wallace, Marvin J. Slepian, and Robert G. Younge on November 18, 2002 and is headquartered in Redwood City, CA. | Health Technology |
Broncus Technologies, Inc.
Broncus Technologies, Inc. Medical SpecialtiesHealth Technology Broncus Technologies is a medical technology company focused on developing and commercializing innovative solutions for lung diseases. With LungPoint™, physicians plan bronchoscopic procedures and navigate to locations in the lungs accurately and quickly. Its line of Yield™ catheters are used to obtain tissue samples and detect blood vessels. Its patented treatment method, Airway Bypass using Exhale® Drug-Eluting Stents, is being investigated to determine if it can provide the first minimally-invasive treatment option for homogeneous, or diffuse, emphysema, the form of the disease experienced by the majority of emphysema patients. | Health Technology |
- Stock Market
- Insiders
- Thomas A. Kramer
